Strauss Kahn dice que el paro seguirá creciendo en 2010

El director general del Fondo Monetario Internacional (FMI), Domenique Strauss-Kahn, aseguró este jueves que los efectos de la crisis financiera internacional seguirán notándose durante los próximos dos años y que el paro crecerá todavía más en 2010 e inc…

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system.

The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.

MANAGUA (AFP) – La Unión Europea (UE) y Centroamérica reanudarán en febrero las negociaciones para la firma de un Acuerdo de Asociación, suspendidas tras el golpe de Estado en Honduras en junio de 2009, con la esperanza de cerrar el tratado en mayo, dijo el jueves un diplomático europeo.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds.

The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization.

News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S.

CONAKRY (AFP) – - Disparos contra la multitud, mujeres violadas, opositores apaleados: numerosos testigos denuncian la violencia inaudita de los militares al aplastar a sangre y fuego el lunes una manifestación pacífica en un estadio de Conakry.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators.

KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro.

Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship. In an emailed statement, Google said it met with governmentofficials to discuss the problem of “pornographic content andmaterial that is harmful to children on the web in China”.

BRUSELAS (AFP) – Los países de la Unión Europea (UE) decidieron mantener vigente por nueve meses el acceso de Estados Unidos a los datos bancarios de ciudadanos europeos, tras haber superado las reticencias de Alemania y Austria, indicó este lunes una fuente diplomática.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.

KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots.

Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine.

LA HABANA (AFP) – El opositor cubano Guillermo Fariñas cumple este miércoles 50 días en huelga de hambre y sed, con complicaciones por una infección, pero dispuesto a continuar su protesta “hasta el final”, según dijo telefónicamente a la AFP.

NEW YORK–(Business Wire)–Fitch Ratings has updated its U.S. CMBS servicer rating criteria to reflectcurrent commercial real estate (CRE) market conditions and their effect onmortgage servicing. These changes have resulted in moderate rating movement(both upgrades and downgrades) for certain servicers, as detailed in severalpress releases also published today. The three main changes to the existing criteria are as follows: –The first change addresses the servicer’s financial rating. Fitch hasincreased its financial weightings for both master and special servicer ratingsto better reflect its significance; –The second relates to employee experience.

Fitch increased its scoring hurdlesin management and staff experience to reflect this view; –Finally, due to the increased complexity of recent vintage CMBS servicing,Fitch has increased emphasis on the servicer’s participation in the CMBS marketover the past few years. Additional information about Fitch’s updated commercial mortgage servicercriteria is available in a full report also released today (‘U.S. CommercialMortgage Servicer Rating Criteria’) which is available at the following headers: Structured Finance >> Operational Risk Group >> Criteria Reports >> CMBS In conjunction with the rollout of the new servicer criteria, Fitch upgraded anddowngraded 16 ratings across 12 companies. Upgrades were made for the followingcompanies: –CWCapital LLC (primary and master servicer); –CWCapital Asset Management LLC (special servicer); –The Bank of New York Mellon – Asset Solutions Division (primary and masterservicer) Downgrades were taken on: –Archon Group, L.P (special servicer); –Centerline Servicing Inc. (special servicer); –CT Investment Management Co., LLC (special servicer); –Hudson Advisors, LLC (special servicer); –J.E Robert Companies (special servicer); –LNR Partners, Inc.

(special servicer); –NCB, FSB (primary servicer); –Ocwen Loan Servicing, LLC (special servicer); –Wachovia Securities (primary servicer); –Wells Fargo Bank (primary and special servicer). Additionally, Fitch has affirmed all of the servicer ratings for the followingcompanies: –Babson Capital Management, LLC; –Bank of America, N.A.; –DB Mortgage Services, LLC; –GE Capital Realty Group; –GEMSA Loan Services, L.P.; –Helios AMC, LLC; –ING Clarion Capital Loan Services, LLC; –KeyBank Real Estate Capital; –Midland Loan Services; –National Cooperative Bank; –ORIX Capital Markets, LLC; –Pacific Life Insurance Company; –Protective Life Insurance Company; –Prudential Asset Resources; –Situs Asset Management; –TriMont Real Estate Advisors, Inc. All individual rating action press releases are available at A detailed list of all Fitch U.S. CMBS servicer ratings is available under thefollowing headers of Fitch’s web site: Structured Finance >> Operational Risk Group >> Special Reports >> CMBS Fitch rates commercial mortgage primary, master, and special servicers on ascale of 1 to 5, with 1 being the highest rating. Within each of these ratinglevels, Fitch further differentiates ratings by plus (+) and minus (-) as wellas the flat rating. Additional detail on these changes is available in Fitch’s June 5 press release(‘New U.S. CMBS Servicer Criteria Will Lead to Moderate Rating Actions’), alsoavailable at Fitch’s rating definitions and the terms of use of such ratings are available onthe agency’s public site, Published ratings, criteria andmethodologies are available from this site, at all times.

Fitch’s code ofconduct, confidentiality, conflicts of interest, affiliate firewall, complianceand other relevant policies and procedures are also available from the ‘Code ofConduct’ section of this site. Fitch Ratings, New YorkStephanie Petosa, +1-212-908-0720Richard Carlson, +1-312-606-2373 (Chicago)Media Relations:Sandro Scenga, +Copyright Business Wire 2009. MOSCOW, June 19 (Reuters) – Russia’s air force lost itssecond fighter plane in three days on Friday when an Su-24crashed in southern Russia, but both pilots survived, Russiannews agencies reported. Russia The air force immediately grounded its fleet of Su-24s, aSoviet era plane also known by the NATO reporting name Fencer,Interfax news agency said.The crew tried to land several times, but technical problemsprevented them from doing so, Interfax quoted a military sourceas saying. “Flight control then gave the command to leave theaerodrome area for a safe place and eject”.

VANCOUVER, Canadá (AFP) – El competidor de luge georgiano Nodar Kumaritashvili falleció este viernes durante un entrenamiento tras chocar contra un poste cuando su luge se desplazaba a unos 140 km por hora, anunció Thomas Bach, integrante del Comité Olímpico Internacional (COI).

The FDA staff memo was released ahead of an advisory panelmeeting, scheduled for Tuesday, where outside experts willreview the safety of various drugs for children. Depakote was once a blockbuster for Abbott but salesdropped sharply after generic competitors became available.First-quarter sales for the drug were $110 million. “For many women, Depakote may be the only effectivemedicine to control their seizures” and doctors and patientsshould evaluate the drug’s risks versus its benefits, Powerssaid. At the same time webelieve that SanJiang will facilitate our ability to get all relatedlogistics in place and to obtain further land assets as needed.”ABOUT SANJIANG AGRICULTURE CO LTD.SanJiang Agriculture Co Ltd. We will provide thetechnology, know-how and management of the operation.

Under the Joint Venture,SanJiang will provide the land and factory buildings. Credit Agricole was also told by the antitrust not to take arole in corporate governance at Intesa Sanpaolo but under itsoriginal pact with Generali it did. The two suspended their original agreement until June 30 andare putting together a revised pact which they hope will satisfyantitrust authorities. TOUGH MEASURES? The source said on Friday that if the antitrust authorityreceived a formal request for an extension of the deadline tosell, it was likely to accept but impose restrictions on thestake. The authority granted an extension to Italy’s biggest bank,UniCredit (CRDI.MI) on selling 3.24 percent of Generali lastyear with the condition of suspending voting rights. Intesa Sanpaolo could face a fine of up to 5 billion eurosfrom the antitrust, newspapers have reported, for failing toensure shareholders meet its requirements. On Friday, Intesa Sanpaolo’s chief executive, CorradoPassera, said its shareholders would find a solution if the bankfaced a fine.

MADRID (AFP) – El Barcelona, líder de la Liga española de fútbol, se impuso este sábado en partido de la 19ª jornada por 3-0 al Valladolid como visitante, con goles del brasileño Daniel Alves (22) y del argentino Lionel Messi (56), y sigue al frente de la competición.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction.

The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.

Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements.

We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, . FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp.

DAMASCO (AFP) – Tres personas murieron este jueves, víctimas de la explosión de un neumático de un autobús procedente de Irán cerca de un lugar de peregrinaje chiita de Damasco, informó el gobierno sirio, que excluyó que se tratara de un atentado terrorista.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx.

HELSINKI (AFP) – - El líder mundial de telefonía móvil Nokia indicó este viernes que se encontraba en medio de una batalla legal en Brasil a raíz de su filial Ovi, debido a que la compañía brasileña Ouvi se queja del parecido con su nombre.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

LONDRES (AFP) – Los vestidos estructurados de lana, los brillos y las joyas volvieron a la Semana de la Moda de Londres este domingo de la mano de Matthew Williamson, en un día dedicado a los grandes talentos británicos como Vivienne Westwood.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits.

DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies.

Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009.

DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers. Thecompany has a policy of early market entry for generics, and as such isgenerally involved in a large amount of litigation. Sales also tend to fluctuateyear on year, as specific exclusivities are gained and expire. Fluoxetine andciprofloxacin are notable examples in recent years. In June 2006, Barr’s offer to acquire Pliva was accepted by the board of theCroatian company. Barr faced strong competition for Pliva from Actavis, althoughthe Icelandic company dropped out of contention after a three month bidding war.The acquisition was completed in October 2006, making Barr one of the world’slargest generic manufacturers, with an enhanced presence in Europe The dealrequired a restructuring process for Barr.

JERUSALÉN (AFP) – Dos militares israelíes y al menos dos combatientes palestinos murieron el viernes en un tiroteo cerca de la franja de Gaza, en momentos en que el primer ministro Benjamin Netanyahu consultaba a sus ministros para responder a las crecientes presiones de Washington sobre la colonización.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010.

“Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering.

YAKARTA (AFP) – ¿Permitirá el Año del Tigre, que comienza el domingo, salvar al más grande de los felinos? Esto esperan los ambientalistas y defensores de los animales, que han lanzado una campaña de movilización masiva en Asia, donde viven los últimos tigres en libertad.

The FDA staff memo was released ahead of an advisory panelmeeting, scheduled for Tuesday, where outside experts willreview the safety of various drugs for children. Depakote was once a blockbuster for Abbott but salesdropped sharply after generic competitors became available.First-quarter sales for the drug were $110 million. “For many women, Depakote may be the only effectivemedicine to control their seizures” and doctors and patientsshould evaluate the drug’s risks versus its benefits, Powerssaid. At the same time webelieve that SanJiang will facilitate our ability to get all relatedlogistics in place and to obtain further land assets as needed.”ABOUT SANJIANG AGRICULTURE CO LTD.SanJiang Agriculture Co Ltd. We will provide thetechnology, know-how and management of the operation.

Under the Joint Venture,SanJiang will provide the land and factory buildings. Credit Agricole was also told by the antitrust not to take arole in corporate governance at Intesa Sanpaolo but under itsoriginal pact with Generali it did. The two suspended their original agreement until June 30 andare putting together a revised pact which they hope will satisfyantitrust authorities. TOUGH MEASURES? The source said on Friday that if the antitrust authorityreceived a formal request for an extension of the deadline tosell, it was likely to accept but impose restrictions on thestake. The authority granted an extension to Italy’s biggest bank,UniCredit (CRDI.MI) on selling 3.24 percent of Generali lastyear with the condition of suspending voting rights.

Intesa Sanpaolo could face a fine of up to 5 billion eurosfrom the antitrust, newspapers have reported, for failing toensure shareholders meet its requirements. On Friday, Intesa Sanpaolo’s chief executive, CorradoPassera, said its shareholders would find a solution if the bankfaced a fine. “Shareholders will find a solution which won’t createproblems for the bank,” Passera said on the sidelines of aconference in Milan He gave no further details. One analyst suggested Intesa Sanpaolo might try to share thepossible fine with Credit Agricole and Generali. Passera also confirmed the bank would soon take advantage ofgovernment-backed bonds aimed at boosting Italian banks’capital.

Intesa shares were down 3.1 percent at 2.265 euros by 1422GMT while Credit Agricole was broadly flat The DJ Stoxx indexof banks .SX7P was up 0.91 percent (writing by Jo Winterbottom, Editing by Andy Bruce) Italy. CINCINNATI–(Business Wire)–Starbucks Corporation (NASDAQ: SBUX) attracted a slew of put traders onThursday, after the java giant recalled more than half a million coffeegrinders. According to data from WhatsTrading , the equity saw nearly 8,750puts cross the tape yesterday, more than doubling its average single-sessionvolume of roughly 4,000 contracts. Most active was the July 14 put, which saw about 5,700 contracts change handsyesterday. The at-the-money option – which assumes front-month status after theclosing bell today – saw open interest climb from 5,948 to 10,932 overnight,suggesting most of the activity was of the buy-to-open variety. What’s more, theSBUX July 14 put remains popular today, with nearly 1,800 contracts exchangedwithin the first hour of trading. To continue reading this article, click here: http://’s Investment ResearchAndrea Kramer, Copyright Business Wire 2009.

FIAMBALÁ, Argentina (AFP) – El piloto francés Cyril Despres (KTM) ganó este lunes en la categoría motos la tercera etapa del Rally-raid Dakar-2010, disputada en Argentina entre La Rioja y Fiambalá (norte) sobre un recorrido de 812 kilómetros.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction.

The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S.

Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements.

We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, . FREDERICK, MD, Jun 19 (MARKET WIRE) — BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive,disposable drug-free anti-inflammatory devices, today provided itsinvestors with a summary of the conference call held after the marketclosed on Thursday, June 18th. On the conference call, the managementteam discussed the numerous ongoing clinical trials, expected FDAsubmissions and the Company’s marketing plans through the end of theyear.

LONDRES (AFP) – Manchester United logró una convincente e importante victoria este domingo en terreno del Arsenal (3-1), con lo que sigue en segunda posición en la Premier League, tras la disputa de la 24ª jornada, a un punto del líder Chelsea, que el sábado ganó en campo del Burnley (2-1).

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.

Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S.

securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext.

LOS ÁNGELES (AFP) – Una de las mujeres que podría haber tenido un romance con el golfista Tiger Woods canceló una conferencia de prensa en Los Ángeles este jueves, en medio de nuevas versiones sobre su relación con el deportista.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system.

The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.

VIENA (AFP) – Unos 174 casos de maltratos y abusos sexuales en instituciones católicas de Austria fueron denunciados tras la implantación hace dos semanas de un número de teléfono especial para recibir las denuncias, informó este viernes la asociación Plataforma de Víctimas de la Violencia de la Iglesia.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment. With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits.

DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster.

In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering.

Barr Pharmaceuticals is one of the USA’s leading generic manufacturers. Thecompany has a policy of early market entry for generics, and as such isgenerally involved in a large amount of litigation. Sales also tend to fluctuateyear on year, as specific exclusivities are gained and expire. Fluoxetine andciprofloxacin are notable examples in recent years. In June 2006, Barr’s offer to acquire Pliva was accepted by the board of theCroatian company. Barr faced strong competition for Pliva from Actavis, althoughthe Icelandic company dropped out of contention after a three month bidding war.The acquisition was completed in October 2006, making Barr one of the world’slargest generic manufacturers, with an enhanced presence in Europe The dealrequired a restructuring process for Barr. In terms of its own manufacturing, Barr’s leading area of expertise is femalehealthcare, notably oral contraceptives.